Cyclin-dependent kinase inhibitors, p16 and p27, demonstrate different expression patterns in thymoma and thymic carcinoma
Authors:
- 18 June 2014
- journal article
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 62 (11) , 678-684
Abstract
The role of cell cycle inhibitors in tumorigenesis has been proven in various neoplasms; however, their roles in thymic tumors are still unclear. We examined the expression of cell cycle inhibitors such as those of the Cip/Kip family (p21, p27, and p57) and the INK-4/ARF family (p16 and p14) in thymoma and thymic carcinoma. Samples from 41 thymoma and 14 thymic carcinoma patients, and 34 normal thymic tissue samples were prepared for the study. Immunohistochemical analysis using antibodies to p21, p27, p57, p16, and p14 was carried out, and the positivity for these inhibitors in each group was estimated in terms of their subcellular location and percentage of cells showing positive staining. Nuclear p27 showed a stepwise decrease (p < 0.0001), and the cytoplasmic p27 showed a stepwise increase (p < 0.0001) in expression level with the increase in malignancy. p16 in both the nucleus and cytoplasm showed a stepwise increase (p < 0.0001) in expression level with the increase in malignancy. However, as for p21, p57, and p14, there was almost no nuclear or cytoplasmic expression in each group. Our findings suggest that low nuclear and high cytoplasmic p27 expression levels, and high nuclear and cytoplasmic p16 expression levels may correlate with the increase in thymic malignancy.Keywords
This publication has 29 references indexed in Scilit:
- Immunohistochemical Expression of p16, p21, p27 and Cyclin D1 in Oral Nevi and MelanomaHead and Neck Pathology, 2012
- Regulatory Mechanisms of Tumor Suppressor P16INK4Aand Their Relevance to CancerBiochemistry, 2011
- Four faces of cellular senescenceJournal of Cell Biology, 2011
- Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinomaInternational Journal of Experimental Pathology, 2010
- p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumoursHistopathology, 2010
- Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinomaJournal of Cancer Research and Clinical Oncology, 2009
- Negative cell cycle regulator 14-3-3σ stabilizes p27 Kip1 by inhibiting the activity of PKB/AktOncogene, 2006
- Long‐term disease‐free survival of patients with radically resected thymomasCancer, 2005
- Expression of cyclins D1, D3 and p27 in thymic epithelial tumorsInteractive CardioVascular and Thoracic Surgery, 2004
- Cancer Cell CyclesScience, 1996